SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,542.44 43.27
( 0.06%)

Global Indices

Nasdaq

54,056.75 150.65
(0.28%)

Dow Jones

7,778.11 47.15
(0.61%)

Hang Seng

66,870.65 1,263.94
(1.93%)

Nikkei 225

10,909.12 41.23
(0.38%)

Forex

USD-INR

95.20 0.13
(0.14%)

EUR-INR

109.83 0.08
(0.08%)

GBP-INR

128.13 0.14
(0.11%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Unjha Formulations Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531762

INE576D01015

8.5780605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

23.1

10.87

EPS(TTM)

Face Value()

Div & Yield %

1.05

Back

Unjha Formulations standalone net profit rises 9.09% in the December 2025 quarter

Feb 04,2026

Net profit of Unjha Formulations rose 9.09% to Rs 0.24 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024. Sales rose 17.29% to Rs 4.41 crore in the quarter ended December 2025 as against Rs 3.76 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4.41	3.76	17
OPM %	5.67	6.12	-
PBDT	0.28	0.24	17
PBT	0.24	0.22	9
NP	0.24	0.22	9

78,542.44 43.27 ( 0.06%)

54,056.75 150.65 (0.28%)

7,778.11 47.15 (0.61%)

66,870.65 1,263.94 (1.93%)

10,909.12 41.23 (0.38%)

95.20 0.13 (0.14%)

109.83 0.08 (0.08%)

128.13 0.14 (0.11%)

0.60 0.00 (-0.12%)